Dr Darragh McCafferty, ProAxsis’ Head of Assay Development, will be presenting new data on the company’s ongoing project to develop a quantitative version of its neutrophil elastase point-of-care test (NEATstik®) at the Irish Thoracic Society (ITS) annual conference, taking place in virtual format between the 19th-20th November.
Dr McCafferty will be presenting a poster, entitled “The Quantitative Measurement of Active Neutrophil Elastase in Sputum using a Point of Care Test and Reader Device”, during the E-poster Review & Discussion session on the 19th of November between 8am and 9am. This project is being conducted collaboratively with the Connected Health Innovation Centre (CHIC) team at Ulster University.
Following the conference, copies of the e-poster will be available online at www.proaxsis.com. For further information on how ProAxsis can support with the measurement of inflammatory biomarkers, including active protease biomarkers and cytokines, or for any other queries, please contact email@example.com or phone us on +44 (0) 28 9073 0444.